Pritzlaff, Mary
Summerour, Pia
McFarland, Rachel
Li, Shuwei
Reineke, Patrick
Dolinsky, Jill S.
Goldgar, David E.
Shimelis, Hermela
Couch, Fergus J.
Chao, Elizabeth C.
LaDuca, Holly
Funding for this research was provided by:
National Cancer Institute (CA192393, CA116167, CA176785)
Article History
Received: 8 December 2016
Accepted: 9 December 2016
First Online: 22 December 2016
Compliance with ethical standards
:
: Mary Pritzlaff, Pia Summerour, Shuwei Li, Patrick Reineke, Jill S. Dolinsky, Rachel McFarland, and Holly LaDuca are employees of Ambry Genetics. Jill S. Dolinsky and Elizabeth Chao are stock holders of Ambry Genetics. The other authors have nothing to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required. The research presented here complies with the current laws of the United States of America.
: This article does not contain any studies with animals performed by any of the authors.